1. Home
  2. PCVX

PCVX

Vaxcyte Inc.

Logo Vaxcyte Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SAN CARLOS
Market Cap: 7.0B IPO Year: 2020
Target Price: $89.50 AVG Volume (30 days): 845.7K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.14 EPS Growth: N/A
52 Week Low/High: $35.53 - $82.04 Next Earning Date: 05-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: